Ripasudil drops for FED patients having cataract surgery
Treatments studied
Part of Eyes & vision, Genetic & congenital clinical trials.
This trial tests if ripasudil eye drops can help people with Fuchs' endothelial dystrophy (FED) during and after cataract surgery. It aims to see if the drops protect the eye's inner layer and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Fuchs' endothelial dystrophy (FED) and are scheduled for cataract surgery
- You are older than 50 years
- You can provide written consent and attend follow-up visits for up to 12 months after surgery
- You are not using only one functional eye
- You have not used ripasudil before or have certain other eye diseases, heart, or kidney problems
- You have no known allergy to any ingredient in the ripasudil eye drops
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether Glanatec (ripasudil) eye drops help patients with Fuchs endothelial dystrophy get better results from Descemet stripping surgery. It may help improve vision and reduce symptoms for people whose vision problems come mainly from the Fuchs changes in the cornea.
This study tests whether special eye drops (Rho-kinase inhibitors) can improve the health of the cornea in people who have both Fuchs endothelial corneal dystrophy and glaucoma. The drops may help reduce corneal swelling and preserve your vision.
This study compares two different eye drops, rebamipide and diquafosol, to see which one works better for treating dry eye in people having cataract surgery. The goal is to find the best way to manage dry eye symptoms during the surgery period.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
This study compares two types of cataract surgery in people with Fuchs' dystrophy: one using a laser and the standard method. It looks at which approach gives better results for the cornea and vision.
This Phase 2 study tests whether eye drops containing a medicine called N-acetylcysteine (NAC) can reduce damaging “reactive oxygen” in people with advanced Fuchs’ endothelial corneal dystrophy (FECD). It involves people who need a special cornea transplant (DMEK) at the same time as cataract surgery, aiming to improve cornea healing and vision.
Hear when a new Fuchs' Endothelial Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.